Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Tolerance of the association sucralfate / Cu-Zn salts in radiation dermatitis].
De Rauglaudre G, Courdi A, Delaby-Chagrin F, d'Hombres A, Hannoun-Levi JM, Moureau-Zabotto L, Richard-Tallet A, Rouah Y, Salem N, Thomas O, Nocera T, Mery S, Merial-Kieny C. De Rauglaudre G, et al. Ann Dermatol Venereol. 2008 Jan;Spec No 1:11-5. doi: 10.1016/S0151-9638(08)70092-9. Ann Dermatol Venereol. 2008. PMID: 18342112 Clinical Trial. French.
[Dose-response relationship in radiotherapy: an evidence?].
Chauvet B, de Rauglaudre G, Mineur L, Alfonsi M, Reboul F. Chauvet B, et al. Among authors: de rauglaudre g. Cancer Radiother. 2003 Nov;7 Suppl 1:8s-14s. Cancer Radiother. 2003. PMID: 15124539 Review. French.
[Respiratory synchronization and breast radiotherapy].
Mège A, Ziouèche-Mottet A, Bodez V, Garcia R, Arnaud A, de Rauglaudre G, Pourel N, Chauvet B. Mège A, et al. Among authors: de rauglaudre g. Cancer Radiother. 2016 Oct;20(6-7):576-82. doi: 10.1016/j.canrad.2016.07.072. Epub 2016 Aug 31. Cancer Radiother. 2016. PMID: 27592267 Review. French.
Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial.
Gladieff L, Ferrero A, De Rauglaudre G, Brown C, Vasey P, Reinthaller A, Pujade-Lauraine E, Reed N, Lorusso D, Siena S, Helland H, Elit L, Mahner S. Gladieff L, et al. Among authors: de rauglaudre g. Ann Oncol. 2012 May;23(5):1185-1189. doi: 10.1093/annonc/mdr441. Epub 2011 Oct 5. Ann Oncol. 2012. PMID: 21976386 Free article. Clinical Trial.
CA-125 ELIMination Rate Constant K (KELIM) Is a Marker of Chemosensitivity in Patients with Ovarian Cancer: Results from the Phase II CHIVA Trial.
You B, Robelin P, Tod M, Louvet C, Lotz JP, Abadie-Lacourtoisie S, Fabbro M, Desauw C, Bonichon-Lamichhane N, Kurtz JE, Follana P, Leheurteur M, Piano FD, Ferron G, De Rauglaudre G, Ray-Coquard I, Combe P, Chevalier-Place A, Joly F, Leary A, Pujade-Lauraine E, Freyer G, Colomban O. You B, et al. Among authors: de rauglaudre g. Clin Cancer Res. 2020 Sep 1;26(17):4625-4632. doi: 10.1158/1078-0432.CCR-20-0054. Epub 2020 Mar 24. Clin Cancer Res. 2020. PMID: 32209570 Clinical Trial.
21 results